Zenotech Laboratories Share Price Today

Zenotech Laboratories Q2FY27 Results: Net loss widens to ₹257 lakh

Net loss widened to ₹257.33 lakh in Q2FY27 from ₹83.65 lakh in Q2FY26. Revenue from operations fell 40% YoY to ₹613.15 lakh. Employee benefit expenses rose to ₹469.30 lakh from ₹380.44 lakh. Trade receivables dropped significantly to ₹187.07 lakh from ₹877.68 lakh.

Zenotech Laboratories Q4FY26 results: Net loss ₹107 lakh, revenue up 1.5%

Zenotech Laboratories reported a net loss of ₹107.21 lakh in FY26 versus a profit of ₹561.29 lakh in FY25. Revenue grew 1.5% to ₹3,956.20 lakh despite a 15% rise in volumes. All AGM resolutions passed, including financial adoption and director re-appointment. Material related party transaction with Sun Pharma approved by 78.17% of public shareholders.

Zenotech Laboratories releases FY26 annual report, 37th AGM notice

Zenotech Laboratories released its FY26 annual report and 37th AGM notice. The AGM is scheduled for September 25, 2026, via video conferencing. Remote e-voting runs from September 22 to September 24, 2026. Shareholders must be on record by September 18, 2026, to vote.

Zenotech Laboratories narrows Q1FY26 loss as revenue rises 11%

Zenotech Laboratories narrowed its Q1FY26 net loss to ₹45.55 lakh from ₹98.96 lakh in the previous year, while revenue grew 11% to ₹959.64 lakh. The improvement was driven by stable rental income, although total expenses increased by 30%, impacting margins.

Zenotech Laboratories Clarifies No Material Information Withheld Following BSE Price Movement Query

Zenotech Laboratories Limited responded to BSE's query about recent stock price movement, confirming full compliance with SEBI disclosure regulations. The company stated that no material information has been withheld that could impact stock price behavior, addressing BSE's specific inquiry under Regulation 30 of SEBI (LODR) Regulations, 2015. The clarification was issued on April 10, 2026, by Company Secretary Abdul Gafoor Mohammad.

Zenotech Laboratories Submits Q4FY26 Compliance Certificate Under SEBI Regulations

Zenotech Laboratories Limited submitted its compliance certificate under SEBI Regulation 74(5) for Q4FY26 quarter ended March 31, 2026. The certificate from KFin Technologies Limited confirms proper processing of securities dematerialization, with all regulatory requirements met including timely substitution of depository names in member registers. Company Secretary Abdul Gafoor Mohammad filed the documentation on April 07, 2026, maintaining the company's regulatory compliance standards.